ANIP: ANI Pharmaceuticals Inc

ANIP News

• 15:13 J&J Ends Imaavy Development in Rheumatoid Arthritis Post Study Failure
• 13:31 Ani Pharmaceuticals stock hits 52-week high at 93.0 USD
• 13:15 Adaptive Biotechnologies Corporation (ADPT) Hits Fresh High: Is There Still Room to Run?
• 16:00 ANI Pharmaceuticals (ANIP) is a Great Momentum Stock: Should You Buy?
• 13:17 IOVA Stock Drops 6% on $350M Common Stock Offering
• 16:45 Is ANI (ANIP) a Solid Growth Stock? 3 Reasons to Think "Yes"
• 13:55 GILD Stock Slips as CVS Health Excludes New HIV Drug Yeztugo
• 13:40 Is Amarin (AMRN) Stock Outpacing Its Medical Peers This Year?
• 13:15 ANI Pharmaceuticals, Inc. (ANIP) Hits Fresh High: Is There Still Room to Run?
• 17:12 Ani Pharmaceuticals stock hits 52-week high at 90.43 USD
• 22:52 Axon, DoorDash, Harmony Gold Among Today's Best Stocks To Buy And Watch: Check Out New Names Added To IBD Stock Lists
• 14:41 ANI Pharmaceuticals stock price target raised to $77 from $65 at Truist Securities
• 13:30 ANI (ANIP) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
• 11:27 ANI Pharmaceuticals stock price target raised to $93 from $84 at H.C. Wainwright
• 18:48 ANI Pharmaceuticals stock price target raised to $93 from $84 at H.C. Wainwright
• 13:32 Ani Pharmaceuticals stock hits 52-week high at 77.86 USD
• 12:41 ANI Pharma earnings beat by $0.40, revenue topped estimates
• 12:00 ANI Pharmaceuticals (ANIP) Q2 Earnings and Revenues Surpass Estimates
• 21:50 Sutro Biopharma, Inc. (STRO) Reports Q2 Loss, Beats Revenue Estimates
• 18:00 Constellation Software, Under Armour, Muenchener Rueckver set to report Friday
• 12:50 How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings
• 14:00 Kymera Therapeutics, Inc. (KYMR) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
• 20:14 CG Oncology wins Delaware jury trial against ANI Pharmaceuticals
• 14:00 ANI Pharmaceuticals (ANIP) Earnings Expected to Grow: What to Know Ahead of Q2 Release